How to work with and transport Biological Agents and Toxins: A primer

Plasmids and other extracted RNA/ gDNA from non-pathogenic organisms, ie., those NOT listed or covered in BATA list of schedules do NOT fall under the BATA but rather under the Chemicals category. Hence, users need to prepare packages according to internationally accepted standards for their shipment. No special permits from BATA related issues are needed. Please note that for all or any work with BATA agents or its components, approval is first required at the institutional level by the IBC, prior to AVA application. MOH has also informed OSHE that life science laboratories should use:

• WHO Biosafety Manual (3rd edition).
  
  If the plasmids and RNA or DNA or any type is extracted from a biological agent listed in the schedules of BATA, then they will have to take caution in the shipment. Please refer to the pdf documents attached and the websites. Applications for an AVA import/transshipment permit should be made through the TradeNet system,

For procurement &/or shipment of genetically modified organisms: For imports of genetically-modified organism (GMO), importers should seek approval from the Genetic Modification Advisory Committee (GMAC) before application for the import/transshipment permit through TradeNet. Please consult the IATA guidelines and comply with the receivers' guideline as well. This is because if problems arises during transhipment, we might be held responsible. This will be especially true for GMOs. A copy of the IATA guidelines is actually purchased and is with Mdm Loy.

These are easy to read 1-2 page circulars on what needs to be done on BATA or related issues. I found them to be highly relevant and easy to interpret -no legal jargons.

• AVA circular on BATA and Shipment
• MOH Circular on BATA
  
  This is a list of biological agents and toxins in the BATA schedules
  List of BA and toxins

PLEASE REFER TO THE FOLLOWING TWO EXCELLENT WEBSITE RESOURCES:

• MOH Biosafety Website - A must-read for anything on BATA and related issues.
• Genetic Modification Advisory Committee Website